Valuation: Astellas Pharma Inc.

Market Cap 4,031B 25.47B 22.74B 21.22B 19.27B 36.26B 2,466B 36.62B 255B 99.62B 1,253B 95.62B 93.54B P/E 2027 *
10.5x
P/E 2028 * 11.1x
Enterprise Value 3,972B 25.09B 22.41B 20.9B 18.99B 35.73B 2,430B 36.08B 251B 98.16B 1,235B 94.21B 92.17B EV / Sales 2027 *
1.69x
EV / Sales 2028 * 1.62x
Free-Float
98.92%
Yield 2027 *
3.57%
Yield 2028 * 3.7%
1 day-0.28%
1 week-1.66%
Current month-1.87%
1 month-3.34%
3 months+7.66%
6 months-14.87%
Current year+6.85%
1 week 14.04
Extreme 14.04
14.59
1 month 13.92
Extreme 13.92
15.43
Current year 12.82
Extreme 12.8175
17.35
1 year 10.03
Extreme 10.03
17.35
3 years 8.37
Extreme 8.37
17.35
5 years 8.37
Extreme 8.37
18.18
10 years 8.37
Extreme 8.37
18.46
Manager TitleAgeSince
Chief Executive Officer 64 2023-02-09
Director of Finance/CFO 55 2023-10-31
Compliance Officer - 2025-03-31
Director TitleAgeSince
Chairman 66 2023-02-09
Director/Board Member 64 2019-05-31
Director/Board Member 59 2023-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.28%-1.66% - - 25.47B
-1.61%+1.72%+38.30%+106.93% 1,043B
-0.76%-0.84%+35.21%+62.70% 618B
+0.39%+4.81%+17.81%+83.77% 481B
-0.29%-0.99%+64.79%+37.06% 351B
+1.23%+3.15%+21.46%+42.16% 338B
+0.82%+1.93%+11.22%+34.55% 269B
+1.05%+1.21%-7.16%+10.67% 244B
-1.37%+0.04%+38.29%+52.33% 220B
+0.17%-0.27%+24.40%+96.82% 182B
Average -0.06%+0.28%+27.15%+58.55% 416.3B
Weighted average by Cap. -0.34%+0.60%+30.54%+69.10%

Financials

2027 *2028 *
Net sales 2,347B 14.83B 13.24B 12.35B 11.22B 21.11B 1,436B 21.32B 148B 58B 730B 55.66B 54.46B 2,189B 13.83B 12.35B 11.52B 10.47B 19.7B 1,340B 19.89B 138B 54.11B 681B 51.93B 50.81B
Net income 367B 2.32B 2.07B 1.93B 1.75B 3.3B 224B 3.33B 23.18B 9.07B 114B 8.7B 8.51B 346B 2.18B 1.95B 1.82B 1.65B 3.11B 211B 3.14B 21.84B 8.54B 107B 8.2B 8.02B
Net Debt -59.18B -374M -334M -311M -283M -532M -36.21B -538M -3.74B -1.46B -18.4B -1.4B -1.37B -481B -3.04B -2.71B -2.53B -2.3B -4.32B -294B -4.37B -30.37B -11.88B -149B -11.4B -11.15B
Projected Income Statement - Annual - Astellas Pharma Inc.
Logo Astellas Pharma Inc.
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Employees
14,099
Date Price Change Volume
26-10-08 US$14.20 -0.28% 95,020
26-10-07 US$14.24 +0.64% 107,593
26-10-06 US$14.15 -0.42% 101,048
26-10-05 US$14.21 -0.77% 97,181
26-10-02 US$14.32 -0.83% 92,997
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Astellas Pharma Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,248.00JPY
Average target price
2,529.29JPY
Spread / Average Target
+12.51%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Astellas Pharma Inc.